Ocd meds
Pro Research Analysisby 
Searched over 200M research papers for "ocd meds"
Pharmacological Treatments for Obsessive-Compulsive Disorder (OCD)
Selective Serotonin Reuptake Inhibitors (SSRIs) and Clomipramine
Selective serotonin reuptake inhibitors (SSRIs) are the most commonly prescribed medications for OCD. Prolonged administration of SSRIs has been shown to be highly effective in reducing OCD symptoms 15. Clomipramine, a tricyclic antidepressant, is also effective but often associated with more severe side effects compared to SSRIs . Combining SSRIs or clomipramine with cognitive behavioral therapy (CBT) or exposure and response prevention (ERP) yields the best outcomes .
Augmentation Strategies for Treatment-Resistant OCD
For patients who do not respond adequately to SSRIs or clomipramine, several augmentation strategies are available. Adding atypical antipsychotics like risperidone can be beneficial, although CBT/ERP remains superior in efficacy and has fewer side effects 17. Buprenorphine, a partial-opioid agonist, has shown promise in reducing OCD symptoms more rapidly than placebo, although its effects may not be sustained long-term . Glutamate-modulating drugs such as memantine, lamotrigine, and ketamine also show potential, but more research is needed to confirm their efficacy 49.
Complementary and Alternative Medicine (CAM)
Complementary and alternative medicine (CAM) approaches, including mindfulness meditation, electroacupuncture, and certain herbal medicines, have shown some positive results in treating OCD. However, the evidence is generally of low quality and further rigorous studies are needed 26. Nutraceuticals like glycine and N-acetylcysteine have also demonstrated efficacy in some studies, but these findings require replication .
Rapid-Onset Treatments
Ketamine, known for its rapid antidepressant effects, has also been investigated for its potential rapid anti-obsessive effects. Initial studies indicate that ketamine can significantly reduce OCD symptoms within hours of administration, although these effects are not sustained and typically revert to baseline within a week . This suggests that while ketamine may offer temporary relief, it is not a long-term solution.
Conclusion
SSRIs and clomipramine remain the cornerstone of pharmacological treatment for OCD, particularly when combined with CBT or ERP. For treatment-resistant cases, augmentation with atypical antipsychotics, buprenorphine, or glutamate-modulating drugs may offer additional benefits. CAM approaches and rapid-onset treatments like ketamine show promise but require further validation. Personalized treatment strategies, potentially guided by pharmacogenomics, could improve outcomes for patients with refractory OCD.
Sources and full results
Most relevant research papers on this topic